Recommended Posts

Researchers announced Tuesday the beginning of a FDA-approved clinical trial that uses umbilical cord blood stem cells to ?cure? autism.

Dr. Michael Chez, director of pediatric neurology at Sutter Neuroscience Institute in Sacramento, Calif., said he and his colleagues have been processing the trial for more than a year now, and they have high hopes it will succeed.

?What we are looking at, is cases that don?t have an obvious genetic link,? Chez told FoxNews.com. ?Patients that we presume something went wrong with their brains, which caused a change to autistic features.?

In other words, the trial?s patients will essentially have no reason to have autism ? or at least no genetic markers for the disease. This means they must have presumably developed it through another factor, such as the environment or exposure to an infection.

Chez got the idea to ?treat? autism with cord blood stem cells when he observed the cells radically cure a little boy who had cerebral palsy.

Rydr?s parents chose to bank his cord blood at birth with CBR ? a cord blood storage company based in Arizona that will provide Chez with participants for his trial ? in hopes Rydr could one day use it as treatment.

Rydr received his first infusion at 2 years old. This was a child who couldn?t walk, talk or eat on his own ? but he started to crawl immediately.

After the second infusion, he began walking and talking ? even jumping and running.

Autism is a developmental disorder that appears in a child?s first three years of life, according to the National Institutes of Health. One in 88 U.S. children have it, and it affects one in 54 boys. The condition impacts the brain?s normal development of social and communication skills ? sometimes mildly, sometimes extremely.

more

  • Like 1
This topic is now closed to further replies.